Definitive Contract 75N93023C00046
Award Date
9/30/23
Potential Completion Date
9/29/28
Potential Value
$7.1M
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
University System Of Maryland
NAICS Category
541512 - Computer Systems Design Services
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21201, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
24
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $29,057,109.85 definitive federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) for biomedical research and development. The contract has no set-aside designation. UMB, a major public research university, is the prime contractor and frequently receives federal contracts and grants for its expertise in areas such as medicine, nursing,...
This is a definitive federal contract awarded by the Department of Health and Human Services' National Institutes of Health to the University of Maryland, Baltimore (UMB) for an Adjuvant Development Program. The $7,110,426.96 contract has a period of performance through September 29, 2024 and uses a cost no fee pricing type. UMB is the prime contractor, and the contract is not set aside for any specific business category. The contract supports biomedical research and product development, with...
The University of Maryland, Baltimore (UMB) has been awarded a $7,594.08 firm fixed price purchase order contract by the National Institute of Allergy and Infectious Diseases (NIAID) for micro-satellite testing and pyro-sequencing services. UMB, a major public research university, frequently receives federal contracts and grants to support its biomedical and clinical research activities. This contract, which is not set aside, is likely part of a larger research initiative at NIAID, the...
This is a federal contract award to the University of Maryland, Baltimore (UMB) from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The contract, valued at $63,079,974.98, is for providing product development support services related to medical countermeasures against radiological threats. The contract was awarded on September 30, 2005 and has a completion date of November 21, 2013. There is no set-aside designation for this award,...
This is a $3,603,949.00 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Vehicle (IDV). The contract supports vaccine and treatment evaluation activities, which is a major program of NIAID. There was no set-aside designation for this award. UMB, the prime contractor, is a leading public research university that...
<p>The federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University System of Maryland as the prime contractor. The 7-year contract, valued at $844,451.00, is for "BIOMEDICAL (BASIC)" services and does not have a set-aside designation. The contract was awarded on July 15, 2003, with a completion date of July 13, 2010. The contract type is a Definitive Contract with a Cost No Fee pricing type.</p>
This is a $358,696 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Vehicle (IDV). The order supports a base award for HHSN272201300022I, with a total ceiling value of $1,033,104.95 and an ultimate completion date of July 11, 2023. The award does not have...
This is a $81,904,328.96 cost-no-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the University of Maryland, Baltimore (UMB) for radiation/nuclear medical countermeasure product development support services. The contract supports the development of medical countermeasures against radiation and nuclear threats, which aligns with NIAID's mission to conduct and support research to...
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to the University of Maryland, Baltimore (UMB) on April 10, 2015 and has a ceiling value of $882,112.66. It is a task order under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Vehicle (IDV), which allows NIAID to place orders for medical research and services...
This federal contract award to the University of Maryland, Baltimore (UMB) was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for Vaccine Treatment and Evaluation Units (VTEU). The $910,006.01 contract is a delivery order under the VTEU indefinite delivery vehicle (IDV), which allows NIAID to order various medical research and clinical trial services from UMB as needed. The contract has no set-aside designation. As...